Drugs / Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT03360708 | Nov 2013 → Jun 2021 | giant cell glioblastoma, gliosarcoma | Mayo Clinic | Completed | No outcome recorded |
| Phase 0 | NCT01957956 | Nov 2013 → Nov 2016 | giant cell glioblastoma, gliosarcoma | Mayo Clinic | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03360708 ↗ |
| Action | Deplete | “to kill tumor cells” NCT03360708 ↗ |
| Modality | Vaccine | “malignant glioma tumor lysate-pulsed autologous dendritic cell vaccine” NCT01957956 ↗ |